Perceptive Xontogeny Venture Fund
Overview
Xontogeny (zon-TOJ-uh-nee) is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Specifically, we partner with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.\\At Xontogeny, we believe that scientific founders supply the passion and determination integral to the success of their companies. While the foundation of success is good science, how that science is developed from inception to maturity serves as the critical pathway. Therefore, we focus on supporting the entrepreneur's pursuit and optimizing the development pathway with an exceptionally talented and experienced operational team. With our team's track record of success, entrepreneurs of affiliated companies will gain the support and guidance they need while remaining lean, virtual, and without the financial burden of supporting a full-time team.\\This dynamic model has the additional benefit of supporting the goals of the founding scientists and entrepreneurs to retain more control and equity, while increasing the chance of accessing investment, and ultimately development success.
Investment Focus
- Innovative healthcare technologies
- Strong scientific and technical foundations
- Potential for significant impact in the healthcare industry
- Alignment with Perceptive Advisors' investment strategies and stages
Portfolio Companies
Reach Perceptive Xontogeny Venture Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Perceptive Xontogeny Venture Fund
What sectors does Perceptive Xontogeny Venture Fund invest in?
Perceptive Xontogeny Venture Fund invests in Healthcare, Consumer, FinTech, Life Sciences, Healthcare Services and Pharmaceuticals, and is based in Boston, Massachusetts, United States. Perceptive Xontogeny Venture Fund is listed as a corporate vc in the ConnectSafely investor database.
What stage does Perceptive Xontogeny Venture Fund invest at?
Perceptive Xontogeny Venture Fund backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 20M - 50M.
Which regions does Perceptive Xontogeny Venture Fund invest in?
Perceptive Xontogeny Venture Fund invests across United States, Latin America and Africa.
What companies has Perceptive Xontogeny Venture Fund invested in?
Perceptive Xontogeny Venture Fund's portfolio includes Achilles Therapeutics, Relay Therapeutics, InSightec, Establishment Labs, SpringWorks Therapeutics, Agile Therapeutics, Saama and Athira Pharma.
How do I contact Perceptive Xontogeny Venture Fund?
Perceptive Xontogeny Venture Fund's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database